Ocrelizumab

Understanding of the peripheral immune system in MS 2:53
Understanding of the peripheral immune system in MS
João José Cerqueira • 27 Apr 2023
Results of ocrelizumab in treatment-naïve patients with early relapsing MS 5:20
Results of ocrelizumab in treatment-naïve patients with early relapsing MS
João José Cerqueira • 27 Apr 2023
Switching from S1Ps or HETs to DRF: results from the EVOLVE-MS-1 study 3:08
Switching from S1Ps or HETs to DRF: results from the EVOLVE-MS-1 study
Barry Singer • 28 Feb 2023
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS 4:32
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS
João José Cerqueira • 28 Oct 2022
Pregnancy and infant outcomes in women with MS receiving ocrelizumab 1:33
Pregnancy and infant outcomes in women with MS receiving ocrelizumab
Celia Oreja-Guevara • 28 Oct 2022
Octopus – inside the progressive MS mega-trial 4:51
Octopus – inside the progressive MS mega-trial
Jeremy Chataway • 27 Sep 2022
Long-term treatment with anti-CD20 mAbs – is it feasible? 2:50
Long-term treatment with anti-CD20 mAbs – is it feasible?
Emma Tallantyre • 23 Sep 2022
Important lines of research in progressive multiple sclerosis 2:54
Important lines of research in progressive multiple sclerosis
Lawrence Steinman • 11 Apr 2022
The CHIMES trial: disease activity & biomarkers in minority patients treated with ocrelizumab 1:12
The CHIMES trial: disease activity & biomarkers in minority patients treated with ocrelizumab
Lilyana Amezcua • 4 Apr 2022
Updates on natalizumab and anti-CD20 antibodies for MS 2:21
Updates on natalizumab and anti-CD20 antibodies for MS
Massimo Filippi • 26 Jun 2022
Personalized B-cell tailored dosing of ocrelizumab in MS 0:56
Personalized B-cell tailored dosing of ocrelizumab in MS
Alyssa Toorop • 26 Jun 2022
Deep learning can predict treatment response in patients with progressive MS 8:42
Deep learning can predict treatment response in patients with progressive MS
Jean-Pierre Falet • 22 Mar 2022
Managing MS relapses during pregnancy 2:25
Managing MS relapses during pregnancy
Kristen Krysko • 4 Apr 2022
Progressive MS treatment – what is next? 1:39
Progressive MS treatment – what is next?
Giancarlo Comi • 23 Mar 2022
Using DMTs beyond patients with active MS 3:14
Using DMTs beyond patients with active MS
Xavier Montalban • 29 Mar 2022
Differential efficacy of DMTs in patients with active and inactive MS 1:30
Differential efficacy of DMTs in patients with active and inactive MS
Xavier Montalban • 29 Mar 2022
The content of VJNeurology is intended for healthcare professionals